Skip to main content
Erschienen in: Supportive Care in Cancer 8/2021

08.01.2021 | Original Article

Oral symptoms in patients with advanced cancer: an observational study using a novel oral symptom assessment scale

verfasst von: Andrew Davies, Alison Buchanan, Jennifer Todd, Amanda Gregory, Kabir Mohammed Batsari

Erschienen in: Supportive Care in Cancer | Ausgabe 8/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of this study was to utilise a novel oral assessment tool (the Oral Symptom Assessment Scale/OSAS) to investigate oral symptoms in a cohort of advanced cancer patients receiving specialist palliative care.

Methods

Participants were asked to complete the OSAS, which asks about the presence of 20 oral symptoms in the previous week (and, if present, about the frequency, the severity, and the amount of distress caused by the symptoms). Patients were also asked to complete the Memorial Symptom Assessment Scale – Short Form, and to rate their performance status.

Results

Two hundred fifty participants completed the study, and 244 (97.5%) participants reported at least one oral symptom on the OSAS. The median number of oral symptoms reported was five (range, 1 to 18), with dry mouth being the most common symptom (83.5% participants). The total number of oral symptoms was higher in younger participants (p = 0.012), female participants (p = 0.048), and those with a worse performance status (p < 0.001). No other oral symptoms were reported by more than two participants. Statistical analysis identified a number of potential oral symptom clusters.

Conclusions

Oral symptoms (and related oral problems) are common in patients with advanced cancer, and are associated with significant morbidity in this group of patients.

Trial registration

CancerTrials.​gov registry reference number: NCT04404920
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Davies A (2010) Oral care in advanced cancer patients. In: Davies AN, Epstein JB (eds) Oral complications of cancer and its management. Oxford University Press, Oxford, pp 279–289CrossRef Davies A (2010) Oral care in advanced cancer patients. In: Davies AN, Epstein JB (eds) Oral complications of cancer and its management. Oxford University Press, Oxford, pp 279–289CrossRef
2.
Zurück zum Zitat Kirkova J, Davis MP, Walsh D, Tiernan E, O’Leary N, LeGrand SB, Lagman RL, Russell KM (2006) Cancer symptom assessment instruments: a systematic review. J Clin Oncol 24:1459–1473CrossRef Kirkova J, Davis MP, Walsh D, Tiernan E, O’Leary N, LeGrand SB, Lagman RL, Russell KM (2006) Cancer symptom assessment instruments: a systematic review. J Clin Oncol 24:1459–1473CrossRef
3.
Zurück zum Zitat Shah S, Davies AN (2001) Medical records vs. patient self-rating. J Pain Symptom Manag 22:805–806CrossRef Shah S, Davies AN (2001) Medical records vs. patient self-rating. J Pain Symptom Manag 22:805–806CrossRef
4.
Zurück zum Zitat Davies A, Epstein J (2010) Introduction. In: Davies AN, Epstein JB (eds) Oral complications of cancer and its management. Oxford University Press, Oxford, pp 1–9CrossRef Davies A, Epstein J (2010) Introduction. In: Davies AN, Epstein JB (eds) Oral complications of cancer and its management. Oxford University Press, Oxford, pp 1–9CrossRef
5.
Zurück zum Zitat Rydholm M, Strang P (2002) Physical and psychosocial impact of xerostomia in palliative cancer care: a qualitative interview study. Int J Palliat Nurs 8:318–323CrossRef Rydholm M, Strang P (2002) Physical and psychosocial impact of xerostomia in palliative cancer care: a qualitative interview study. Int J Palliat Nurs 8:318–323CrossRef
6.
Zurück zum Zitat Li X, Kolltveit KM, Tronstad L, Olsen I (2000) Systemic diseases caused by oral infection. Clin Microbiol Rev 13:547–558CrossRef Li X, Kolltveit KM, Tronstad L, Olsen I (2000) Systemic diseases caused by oral infection. Clin Microbiol Rev 13:547–558CrossRef
7.
Zurück zum Zitat Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655CrossRef Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655CrossRef
8.
Zurück zum Zitat Chang VT, Hwang SS, Feuerman M, Kasimis BS, Thaler HT (2000) The Memorial Symptom Assessment Scale short form (MSAS-SF). Cancer 89:1162–1171CrossRef Chang VT, Hwang SS, Feuerman M, Kasimis BS, Thaler HT (2000) The Memorial Symptom Assessment Scale short form (MSAS-SF). Cancer 89:1162–1171CrossRef
9.
Zurück zum Zitat Portenoy RK, Thaler HT, Kornblith AB, McCarthy Lepore J, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L, Scher H (1994) The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30(A):1326–1336CrossRef Portenoy RK, Thaler HT, Kornblith AB, McCarthy Lepore J, Friedlander-Klar H, Kiyasu E, Sobel K, Coyle N, Kemeny N, Norton L, Scher H (1994) The Memorial Symptom Assessment Scale: an instrument for the evaluation of symptom prevalence, characteristics and distress. Eur J Cancer 30(A):1326–1336CrossRef
10.
Zurück zum Zitat Fischer DJ, Epstein JB, Yao Y, Wilkie DJ (2014) Oral health conditions affect functional and social activities of terminally ill cancer patients. Support Care Cancer 22:803–810CrossRef Fischer DJ, Epstein JB, Yao Y, Wilkie DJ (2014) Oral health conditions affect functional and social activities of terminally ill cancer patients. Support Care Cancer 22:803–810CrossRef
11.
Zurück zum Zitat Davies AN, Broadley K, Beighton D (2001) Xerostomia in patients with advanced cancer. J Pain Symptom Manag 22:820–825CrossRef Davies AN, Broadley K, Beighton D (2001) Xerostomia in patients with advanced cancer. J Pain Symptom Manag 22:820–825CrossRef
12.
Zurück zum Zitat Tranmer JE, Heyland D, Dudgeon D, Groll D, Squires-Graham M, Coulson K (2003) Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the Memorial Symptom Assessment Scale. J Pain Symptom Manag 25:420–429CrossRef Tranmer JE, Heyland D, Dudgeon D, Groll D, Squires-Graham M, Coulson K (2003) Measuring the symptom experience of seriously ill cancer and noncancer hospitalized patients near the end of life with the Memorial Symptom Assessment Scale. J Pain Symptom Manag 25:420–429CrossRef
13.
Zurück zum Zitat Chaushu G, Bercovici M, Dori S, Waller A, Taicher S, Kronenberg J, Talmi YP (2000) Salivary flow and its relation with oral symptoms in terminally ill patients. Cancer 88:984–987CrossRef Chaushu G, Bercovici M, Dori S, Waller A, Taicher S, Kronenberg J, Talmi YP (2000) Salivary flow and its relation with oral symptoms in terminally ill patients. Cancer 88:984–987CrossRef
14.
Zurück zum Zitat Davies AN, Broadley K, Beighton D (2002) Salivary gland hypofunction in patients with advanced cancer. Oral Oncol 38:680–685CrossRef Davies AN, Broadley K, Beighton D (2002) Salivary gland hypofunction in patients with advanced cancer. Oral Oncol 38:680–685CrossRef
15.
Zurück zum Zitat Shorthose K, Davies A (2003) Symptom prevalence in palliative care. Palliat Med 17:723–724CrossRef Shorthose K, Davies A (2003) Symptom prevalence in palliative care. Palliat Med 17:723–724CrossRef
16.
Zurück zum Zitat Sweeney MP, Bagg J (2000) The mouth and palliative care. Am J Hosp Palliat Care 17:118–124CrossRef Sweeney MP, Bagg J (2000) The mouth and palliative care. Am J Hosp Palliat Care 17:118–124CrossRef
17.
Zurück zum Zitat Davies AN, Brailsford SR, Beighton D (2006) Oral candidosis in patients with advanced cancer. Oral Oncol 42:698–702CrossRef Davies AN, Brailsford SR, Beighton D (2006) Oral candidosis in patients with advanced cancer. Oral Oncol 42:698–702CrossRef
18.
Zurück zum Zitat Astvad K, Johansen HK, Holby N, Steptoe P, Ishoy T (2015) Oropharyngeal candidiasis in palliative care patients in Denmark. J Palliat Med 18:940–944CrossRef Astvad K, Johansen HK, Holby N, Steptoe P, Ishoy T (2015) Oropharyngeal candidiasis in palliative care patients in Denmark. J Palliat Med 18:940–944CrossRef
19.
Zurück zum Zitat Sweeney P (2005) Oral hygiene. In: Davies A, Finlay I (eds) Oral care in advanced disease. Oxford University Press, Oxford, pp 21–35 Sweeney P (2005) Oral hygiene. In: Davies A, Finlay I (eds) Oral care in advanced disease. Oxford University Press, Oxford, pp 21–35
20.
Zurück zum Zitat Sweeney MP, Bagg J, Baxter WP, Aitchison TC (1998) Oral disease in terminally ill cancer patients with xerostomia. Oral Oncol 34:123–126CrossRef Sweeney MP, Bagg J, Baxter WP, Aitchison TC (1998) Oral disease in terminally ill cancer patients with xerostomia. Oral Oncol 34:123–126CrossRef
21.
Zurück zum Zitat Wiseman MA (2000) Palliative care dentistry. Gerodontology 17:49–51CrossRef Wiseman MA (2000) Palliative care dentistry. Gerodontology 17:49–51CrossRef
22.
Zurück zum Zitat Gordon SR, Berkey DB, Call RL (1985) Dental need among hospice patients in Colorado: a pilot study. Gerodontics 1:125–129PubMed Gordon SR, Berkey DB, Call RL (1985) Dental need among hospice patients in Colorado: a pilot study. Gerodontics 1:125–129PubMed
23.
Zurück zum Zitat Dong ST, Butow PN, Costa DS, Lovel MR, Agar M (2014) Symptom clusters in patients with advanced cancer: a systematic review of observational studies. J Pain Symptom Manag 48:411–450CrossRef Dong ST, Butow PN, Costa DS, Lovel MR, Agar M (2014) Symptom clusters in patients with advanced cancer: a systematic review of observational studies. J Pain Symptom Manag 48:411–450CrossRef
24.
Zurück zum Zitat Walsh D, Rybicki L (2006) Symptom clustering in advanced cancer. Support Care Cancer 14:831–836CrossRef Walsh D, Rybicki L (2006) Symptom clustering in advanced cancer. Support Care Cancer 14:831–836CrossRef
25.
Zurück zum Zitat Streiner DL, Norman GR (2008) Health measurement scales: a practical guide to their development and use, 4th edn. Oxford University Press, OxfordCrossRef Streiner DL, Norman GR (2008) Health measurement scales: a practical guide to their development and use, 4th edn. Oxford University Press, OxfordCrossRef
Metadaten
Titel
Oral symptoms in patients with advanced cancer: an observational study using a novel oral symptom assessment scale
verfasst von
Andrew Davies
Alison Buchanan
Jennifer Todd
Amanda Gregory
Kabir Mohammed Batsari
Publikationsdatum
08.01.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 8/2021
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-020-05903-1

Weitere Artikel der Ausgabe 8/2021

Supportive Care in Cancer 8/2021 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.